Announcements

Announcements
 
 
BMGF – Gates Foundation  [to 12 Jan 2019]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.
 
 
Bill & Melinda Gates Medical Research Institute    [to 12 Jan 2019]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
 
 
CARB-X   [to 12 Jan 2019]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
 
 
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 12 Jan 2019]
http://cepi.net/
Posted on 07TH JAN 2019 by Mario Christodoulou
CEPI launches call for proposals to develop vaccines against Rift Valley fever and Chikungunya viruses
OSLO (Norway)
The Coalition for Epidemic Preparedness Innovations (CEPI) has launched a call for proposals to develop human vaccines against Rift Valley fever and Chikungunya viruses. This will be CEPI’s third call for proposals since January, 2017. USD$ 48 million of funding will be made available through this call and it is expected to fund up to eight projects.
The broadening of CEPI’s vaccine portfolio to include Rift Valley fever and Chikungunya viruses has been based on wide consultation and advice from CEPI’s Scientific Advisory Committee and on three main criteria: the public health impact of these diseases, that no vaccines are currently available for human use, and the feasibility of vaccine development.
This opportunity will be open, worldwide, to research and development organisations with expertise in vaccine development. The closing date for funding applications is March 5, 2019…
 
 
EDCTP    [to 12 Jan 2019]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.
 
 
Emory Vaccine Center    [to 12 Jan 2019]
http://www.vaccines.emory.edu/
No new digest content identified.
 
 
European Medicines Agency  [to 12 Jan 2019]
http://www.ema.europa.eu/ema/
News and press releases
No new digest content identified.
 
 
European Vaccine Initiative  [to 12 Jan 2019]
http://www.euvaccine.eu/news-events
No new digest content identified.
 
 
FDA [to 12 Jan 2019]
January 07, 2019
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations
 
 
Fondation Merieux  [to 12 Jan 2019]
http://www.fondation-merieux.org/
Mérieux Foundation co-organized event
Dengue pre-vaccination screening based on serostatus: rapid tests and implementation strategies
January 14 – 16, 2019 – Les Pensières Center for Global Helath, Veyrier du Lac (France)
 
 
Gavi [to 12 Jan 2019]
https://www.gavi.org/
No new digest content identified.
 
 
GHIT Fund   [to 12 Jan 2019]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.
 
 
Global Fund  [to 12 Jan 2019]
https://www.theglobalfund.org/en/news/
11 January 2019
Global Fund Announces US$14 Billion Target to Step Up the Fight Against AIDS, TB and Malaria Ahead of Lyon Conference in October 2019
[See Milestones above for detail]
 
 
Hilleman Laboratories   [to 12 Jan 2019]
http://www.hillemanlabs.org/
No new digest content identified.
 
 
Human Vaccines Project   [to 12 Jan 2019]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.
 
 
IAVI  [to 12 Jan 2019]
https://www.iavi.org/newsroom
No new digest content identified.
 
 
IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.
 
 
IVAC  [to 12 Jan 2019]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
No new digest content identified.
 
 
IVI   [to 12 Jan 2019]
http://www.ivi.int/
IVI News & Announcements
January 4, 2019
IVI Director General addresses ‘neglected diseases’ in STAT News
 
 
JEE Alliance  [to 12 Jan 2019]
https://www.jeealliance.org/
No new digest content identified.
 
 
MSF/Médecins Sans Frontières  [to 12 Jan 2019]
http://www.msf.org/
Selected News; Project Updates, Reports
No new digest content identified.
 
 
NIH  [to 12 Jan 2019]
http://www.nih.gov/news-events/news-releases
January 10, 2019
The science is clear: with HIV, undetectable equals untransmittable
— NIH officials discuss scientific evidence and principles underlying the U=U concept.
ARTICLE: RW Eisinger, CW Dieffenbach, AS Fauci. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. Journal of the American Medical Association DOI: 10.1001/jama.2018.21167 (2019).

January 10, 2019
AI approach outperformed human experts in identifying cervical precancer
— Algorithm could revolutionize cervical cancer screening, especially in low-resource settings
 
 
PATH  [to 12 Jan 2019]
https://www.path.org/media-center/
No new digest content identified.
 
 
Sabin Vaccine Institute  [to 12 Jan 2019]
http://www.sabin.org/updates/pressreleases
No new digest content identified.
 
 
UNAIDS [to 12 Jan 2019]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
10 January 2019
Traversing rivers and jungles to reach indigenous peoples in remote parts of Brazil
Indigenous health worker Jijuké Hukanaru Karajá works as a nurse in the Indigenous Health District of Araguaia, named after one of Brazil’s major rivers located in the eastern Amazon basin. She has been working with indigenous peoples for many years and criss-crosses between Brazil’s cities and indigenous villages to provide crucial health services. Ms Karajá feels very proud to be a part of the Brazilian indigenous public health system, having followed in her father’s footsteps…
 
 
UNICEF  [to 12 Jan 2019]
https://www.unicef.org/media/press-releases
Selected Press Releases/Reports/Statements
No new digest content identified.
 
 
Vaccine Confidence Project  [to 12 Jan 2019]
http://www.vaccineconfidence.org/
No new digest content identified.
 
 
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 12 Jan 2019]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.
 
 
Wellcome Trust  [to 12 Jan 2019]
https://wellcome.ac.uk/news
No new digest content identified.
 
 
The Wistar Institute   [to 12 Jan 2019]
https://www.wistar.org/news/press-releases
Press Release
Jan. 8, 2019
First-in-Class DNA-encoded Monoclonal Antibody Therapy Rapidly Advances into the Clinic
Multisector collaboration yields first-in-human clinical trial for testing novel Zika antibody therapy. 
 
 
World Organisation for Animal Health (OIE)   [to 12 Jan 2019]
http://www.oie.int/en/for-the-media/press-releases/2018/
No new digest content identified.

::::::
 
BIO    [to 12 Jan 2019]
https://www.bio.org/insights/press-release
Jan 11 2019
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
“Members of the House have sent a strong signal to the American people about their commitment to prioritizing health security by providing the resources needed to fully prepare for and defend against biological threats. Strengthening the pipeline of medical products, drugs and devices that will safeguard the nation during an emergency or pandemic is vital to our national security.”
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 12 Jan 2019]
http://www.dcvmn.org/
No new digest content identified.
 
 
IFPMA   [to 12 Jan 2019]
http://www.ifpma.org/resources/news-releases/
10 January 2019
R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide
:: The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids
:: Industry moves beyond compliance and reaffirms its commitment to ensuring an ethical framework as a way to increase integrity and trust
:: Industry presents new Code to patients and healthcare professionals
 
 
PhRMA    [to 12 Jan 2019]
http://www.phrma.org/press-room
No new digest content identified.